INSIGHTS INTO THE WORLD OF SEEING
Nerve Regenerative Agents for the Treatment of Eye Disorders
Preclinical up through Phase 2 dry-eye disease clinical trials have shown that NRO-1 enhanced neurite elongation of Retinal Ganglion Cells (RGCs) significantly.
NRO-1 PROGRAMS
PRECLINICAL
PHASE 1
PHASE 2
GLAUCOMA